Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning and welcome to Y-mAbs Therapeutics Third Quarter 2023 Earnings Conference Call. Please note that today’s event is being recorded. At this time, all participants are in a listen-only mode. Instructions for the question-and-answer session will follow after the prepared remarks. […]
Operator: Good morning and welcome to Y-mAbs Therapeutics Third Quarter 2023 Earnings Conference Call. Please note that today’s event is being recorded.
NEW YORK, Oct. 31, 2023 Y-mAbs Therapeutics, Inc. today announced that it will report its financial results for the third quarter ended September 30, 2023, on Monday, November 13, 2023, after.
NEW YORK, Sept. 06, 2023 Y-mAbs Therapeutics, Inc. , a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products.
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q2 2023 Earnings Call Transcript August 11, 2023 Operator: Good morning, and welcome to the Y-mAbs Therapeutics, Inc.’s Earnings Conference Call for the Second Quarter of 2023. At this time, all participants are in a listen-only mode. Instructions for the question-and-answer session will follow after the prepared remarks. As a reminder, […]